| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Koumi Miyasaka, Sakiko Hirofuji, Mika Maezawa, Satoshi Nakao, Moe Yamashita, Nanaka Ichihara, Yuka Nokura, Hirofumi Tamaki, Kazuhiro Iguchi, Mitsuhiro Nakamur. Evaluation of Antipsychotic-Induced Neuroleptic Malignant Syndrome Using a Self-Organizing Map. Cureus. vol 16. issue 8. 2024-10-01. PMID:39350836. |
conclusion the results of this study provide a reference for healthcare providers when predicting the nms characteristics induced by each drug in patients, thereby facilitating the effective treatment of schizophrenia. |
2024-10-01 |
2024-10-03 |
Not clear |
| Wojciech Mędrala, Patryk Rodek, Barbara Alli-Balogun, Aleksandra Barabasz-Gembczyk, Paulina Wójcik, Krzysztof Kuci. Malignant complications of masturbation - a case study. Psychiatria polska. 2022-12-21. PMID:36542768. |
we present a case of a 32-years-old female patient diagnosed with paranoid schizophrenia for many years who has developed neuroleptic malignant syndrome (nms) as a result of long-acting antipsychotic's injection. |
2022-12-21 |
2023-08-14 |
Not clear |
| Seyedhamze Hosseini, Forouzan Elyas. Olanzapine-Induced Neuroleptic Malignant Syndrome. Iranian journal of medical sciences. vol 42. issue 3. 2020-09-30. PMID:28533580. |
we present the case of a 27-year-old man with a history of paranoid schizophrenia that showed signs consistent with nms that occurred after treatment with olanzapine. |
2020-09-30 |
2023-08-13 |
Not clear |
| P Casas Reza, M Gestal Vázquez, Á Outeiro Rosato, S López Álvarez, P Diéguez Garcí. Rocuronium-sugammadex for electroconvulsive therapy management in neuroleptic malignant syndrome: A case report. Revista espanola de anestesiologia y reanimacion. vol 64. issue 2. 2018-03-29. PMID:27424873. |
a review is presented on the treatment options and anaesthetic implications of ect used to handle a patient diagnosed with paranoid schizophrenia in the context of nms. |
2018-03-29 |
2023-08-13 |
Not clear |
| Justine Wittenauer Welsh, A Umair Janjua, Steven J Garlow, Laurie McCormick, Mustafa M Husain, Daniel F Maixner, Richard D Weiner, Adriana P Hermid. Use of Expert Consultation in a Complex Case of Neuroleptic Malignant Syndrome Requiring Electroconvulsive Therapy. Journal of psychiatric practice. vol 22. issue 6. 2017-09-26. PMID:27824784. |
our team at emory university hospital contacted experts at the national network of depression centers (nndc) for clinical guidance concerning a patient with schizophrenia hospitalized in the intensive care unit with a complex case of prolonged delirium secondary to neuroleptic malignant syndrome (nms). |
2017-09-26 |
2023-08-13 |
Not clear |
| Kazutaka Ohi, Aki Kuwata, Takamitsu Shimada, Toshiki Yasuyama, Yusuke Nitta, Takashi Uehara, Yasuhiro Kawasak. Response to benzodiazepines and the clinical course in malignant catatonia associated with schizophrenia: A case report. Medicine. vol 96. issue 16. 2017-05-09. PMID:28422845. |
this case study reports a detailed clinical course of a case of mc associated with schizophrenia initially diagnosed as nms that responded successfully to bzds but not to dantrolene. |
2017-05-09 |
2023-08-13 |
Not clear |
| Takayuki Komatsu, Tomohisa Nomura, Hiroki Takami, So Sakamoto, Keiko Mizuno, Hajime Sekii, Kotaro Hatta, Manabu Sugit. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia. Internal medicine (Tokyo, Japan). vol 55. issue 19. 2017-02-06. PMID:27725556. |
a 42-year-old japanese woman with a 10-year history of schizophrenia was admitted due to a disturbance in consciousness that met the diagnostic criteria for both neuroleptic malignant syndrome (nms) and malignant catatonia. |
2017-02-06 |
2023-08-13 |
Not clear |
| Brian Dean, Shaun Hopper, P Jeffrey Conn, Elizabeth Scar. Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 41. issue 6. 2017-01-05. PMID:26511338. |
changes in bqca allosteric modulation of [(3)h]nms binding to human cortex within schizophrenia and by divalent cations. |
2017-01-05 |
2023-08-13 |
mouse |
| Brian Dean, Shaun Hopper, P Jeffrey Conn, Elizabeth Scar. Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 41. issue 6. 2017-01-05. PMID:26511338. |
surprisingly, there was no change in [(3)h]nms binding to the cortex from this subset or those with schizophrenia but without a marked loss of cortical chrm1. |
2017-01-05 |
2023-08-13 |
mouse |
| Jeannie D Lochhead, Michele A Nelson, Alan L Schneide. Risks and Benefits of Rapid Clozapine Titration. Mental illness. vol 8. issue 1. 2016-07-12. PMID:27403276. |
we present the case of a young man with schizophrenia who developed life threatening neuroleptic malignant syndrome (nms) during rapid clozapine titration and treatment with multiple antipsychotics. |
2016-07-12 |
2023-08-13 |
Not clear |
| Zhiyong Zhao, Hua Zhang, Shaohua Wang, Xiaofeng Che. Sudden discontinuation and reinstitution of olanzapine-associated atypical neuroleptic malignant syndrome in a patient undergoing lung surgery. International journal of clinical and experimental medicine. vol 8. issue 7. 2015-09-18. PMID:26379999. |
here we report a case of nms induced by sudden discontinuation and reinstitution of olanzapine in a patient with schizophrenia during perioperative period of lung resection, drawing attention to adverse events occurring with reinstitution of atypical neuroleptics in high-risk patients. |
2015-09-18 |
2023-08-13 |
Not clear |
| Siddharth Dixit, Manoj Kumar Dutta, Mayank Namde. A Rare Case of Myxedema Coma with Neuroleptic Malignant Syndrome (NMS). Journal of clinical and diagnostic research : JCDR. vol 9. issue 5. 2015-07-09. PMID:26155541. |
we hereby report first case with coexisting myxedema coma and nms in a patient of schizophrenia treated with antipsychotic, where classical symptoms of nms were masked by myxedema coma. |
2015-07-09 |
2023-08-13 |
Not clear |
| Zexiang Ouyang, Li Ch. A case of recurrent neuroleptic malignant syndrome. Shanghai archives of psychiatry. vol 25. issue 4. 2014-07-03. PMID:24991164. |
this report discusses the clinical presentation, possible etiology, pathogenesis and treatment of one case of recurrent nms in a middle-aged woman with schizophrenia. |
2014-07-03 |
2023-08-13 |
Not clear |
| Sylvain Grignon, Jean Ianic Brethes, Martine Chamberland, Daniel B Guimarae. Incipient neuroleptic malignant syndrome with quetiapine/paroxetine combination treatment: atypical presentation and early, successful rechallenge with olanzapine. International journal of psychiatry in clinical practice. vol 9. issue 4. 2014-06-17. PMID:24930930. |
a 26-year-old caucasian male developed incipient neuroleptic malignant syndrome (nms) during the course of paranoid schizophrenia with catatonic signs at admission, while on quetiapine/paroxetine combination treatment. |
2014-06-17 |
2023-08-13 |
Not clear |
| Alexander Koch, Karin Reich, Jan Wielopolski, Marion Clepce, Marie Fischer, Johannes Kornhuber, Norbert Thuerau. Catatonic dilemma in a 33-year-old woman: a discussion. Case reports in psychiatry. vol 2013. 2014-01-13. PMID:24416611. |
catatonic symptoms in schizophrenia as well as in nms might be caused by a lack of striatal dopamine (cs) or dopamine d2 antagonism (nms). |
2014-01-13 |
2023-08-12 |
Not clear |
| Young Kyoung Sa, Hyeon Yang, Hee Kyoung Jung, Jang Won Son, Seong Su Lee, Seong Rae Kim, Bong Yeon Cha, Ho Young Son, Chi-Un Pae, Soon Jib Yo. Olanzapine-induced diabetic ketoacidosis and neuroleptic malignant syndrome with rhabdomyolysis: a case report. Endocrinology and metabolism (Seoul, Korea). vol 28. issue 1. 2014-01-07. PMID:24396655. |
atypical antipsychotics have replaced conventional antipsychotics in the treatment of schizophrenia because they have less of a propensity to cause undesirable neurologic adverse events including extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome (nms). |
2014-01-07 |
2023-08-12 |
Not clear |
| Shrividya Chellam, Dhanwanti S Rajwade, Snehlata O Tavr. Emergency anaesthetic management of a severely anaemic, chronic schizophrenic patient with history of neuroleptic malignant syndrome. Indian journal of anaesthesia. vol 55. issue 6. 2013-03-17. PMID:22223911. |
here, we describe the successful anaesthetic management of a patient of chronic schizophrenia with past history of nms who presented in emergency with active bleeding per rectum and haemoglobin of 3 gm%. |
2013-03-17 |
2023-08-12 |
Not clear |
| Marzieh Assareh, Laleh Koohi Habib. Afebrile Neuroleptic Malignant Syndrome associated with Fluphenazine decanoate: A case report. Iranian journal of psychiatry. vol 5. issue 2. 2012-09-06. PMID:22952496. |
we present this case to alert the clinicians to the potential for inducing afebrile nms.our case is a 41-year-old man with a history of schizophrenia showing signs and symptoms in accordance with nms, 2 weeks after receiving one dose of 12.5 mg fluphenazine decanoate, abruptly following the 3rdsession of ect. |
2012-09-06 |
2023-08-12 |
Not clear |
| Shankar Srinivas Kuchibatla, Sofia Akram Cheema, Kripa S Chakravarthy, Hany George El Saye. A case report of neuroleptic malignant syndrome. BMJ case reports. vol 2009. 2011-11-10. PMID:21686818. |
a 32-year-old male patient with a history of treatment resistant paranoid schizophrenia developed neuroleptic malignant syndrome (nms) during changeover of his antipsychotic medication from zuclopenthixol depot to clozapine. |
2011-11-10 |
2023-08-12 |
Not clear |
| GeumSook Shim, Do-Hyung Kang, Jun Soo Kwo. Probable case of neuroleptic malignant syndrome following administration of antituberculotic drugs in a chlorpromazine-treated patient. Journal of Korean medical science. vol 23. issue 4. 2008-10-07. PMID:18756068. |
we describe a patient with chronic schizophrenia who, in a few days after the addition of antituberculotic drugs to his antipsychotic regimen, developed probable nms without pyrexia. |
2008-10-07 |
2023-08-12 |
Not clear |